<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sixty-four nondepressed, carefully selected senile <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> inpatients underwent two 1.0 mg overnight <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> suppression tests (<z:chebi fb="14" ids="38291">DSTs</z:chebi>) separated by 7 days </plain></SENT>
<SENT sid="1" pm="."><plain>These patients had been in a clinically stable and drug-free state for at least six months prior to testing </plain></SENT>
<SENT sid="2" pm="."><plain>The Modified Ischemic Scale score and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>-9 criteria for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> were used to dichotomize subjects into Alzheimer's and multi-<z:mpath ids='MPATH_124'>infarct</z:mpath> types of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with vascular <z:hpo ids='HP_0000726'>dementias</z:hpo> were significantly more likely to evidence <z:chebi fb="14" ids="38291">DST</z:chebi> nonsuppression, furthermore, <z:chebi fb="14" ids="38291">DSTs</z:chebi> in this group were less reproducible from week to week than <z:chebi fb="14" ids="38291">DSTs</z:chebi> in Alzheimer's patients </plain></SENT>
</text></document>